Companies
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
MENA Remains IP Blackspot
May 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
There has not been much progress concerning intellectual property (IP) protection in the Middle East & North Africa, according to the United States Trade Representative (USTR)'s 2007 "Special 301" report. The list, which monitors the worst IP violators in the world, ranks four countries form the MENA region -Israel, Egypt, Turkey and Lebanon - as 'Priority Watch' nations. Also, Kuwait and Saudi Arabia have retained their positions on the slightly less severe 'Watch